Adaptin Bio, Inc.

APTN

Financials

10-QQ2 ended 06/30/2608/13/26 10-K/AFY 202506/12/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202504/01/26 10-QQ3 ended 09/30/2511/14/25

Disclosures

8-KCurrent report08/25/26 8-KCurrent report04/06/26 8-KCurrent report12/23/25 8-KCurrent report10/06/25 8-K/ACurrent report (amended)04/15/25

Prospectuses and Registrations

424B3Prospectus09/10/26 S-1Registration statement (IPO)08/28/26 424B3Prospectus08/25/26 424B3Prospectus08/20/26 POS AMPost-effective amendment07/21/26

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/10/25 Form 4Insider transaction09/10/25 Form 4Insider transaction09/10/25 Form 4Insider transaction09/10/25 Form 4Insider transaction09/10/25

Other

EFFECTRequest for effectiveness09/09/26 EFFECTRequest for effectiveness07/22/26 D/AD/A06/22/26 NT 10-KLate filing notification (10-K)04/01/26 D/AD/A03/23/26